"UnitedHealth stock climbed 37% in April, finishing at $370.48 on April 30, while Humana stock rose 36%, closing at $236.44. It's a photo finish, but UnitedHealth wins the month."
"Both names entered April deeply oversold after a brutal 2025 of medical loss ratio pressure and Medicare Advantage reimbursement worry. The first jolt came on April 7, when CMS finalized a 2% increase in MA payment rates for 2027."
"UnitedHealth reported Q1 2026 results on April 21 and delivered a clean beat. Adjusted earnings per share came in at $7.23 versus $6.61 expected, with revenue of $111.72 billion."
In April, UnitedHealth Group's stock rose 37% to $370.48, while Humana's stock increased 36% to $236.44. Year to date, UnitedHealth is up 11.63%, contrasting with Humana's decline of 9.14%. Both companies faced challenges in 2025 due to medical loss ratio pressures and Medicare Advantage reimbursement concerns. A 2% increase in MA payment rates for 2027 provided a significant boost. UnitedHealth's Q1 2026 earnings exceeded expectations, with adjusted EPS of $7.23 and revenue of $111.72 billion, leading to an improved medical cost ratio and raised full-year guidance.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]